Oncology
Flowchart Overview
 
3
1
1
2
1
3
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
NRG-BR008-HERO Phase III OPEN TO ACCRUAL
3
7
1
1
11
ARCELLX-ACLX-001-DDBCMA Phase I OPEN TO ACCRUAL
CARGO-CRG-022-101-LBCL Phase II OPEN TO ACCRUAL
CARIBOU-AMPLIFY-CB12A-AML Phase I OPEN TO ACCRUAL
CARIBOU-CAMMOUFLAGE-CB-011A-MM Phase I OPEN TO ACCRUAL
CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
GRACELL-GC012F-CD19-BCMA-001 Phase I/II OPEN TO ACCRUAL
GSK-3377794-LTFU Phase I OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
JUNO-017004-TRANSCEND-CLL Phase I/II OPEN TO ACCRUAL
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL *
4
1
4
1
2
4
2
2
5
4
8
8
6
2
1
2
3
1
3
5
4
3
2
7
1
1
MAYO-ECHO-STUDY Phase II OPEN TO ACCRUAL
5
3
8
1
2
6
1
2
1
1
2
4
2
2
3
6
1
2
1
2
2
3
1
5
1
1
3
5
5
1
5
9
2
1
4
2
2
CARGO-CRG-022-101-LBCL Phase II OPEN TO ACCRUAL
IIT-ABEDIN-PTCY-RUX-GVHD Phase II OPEN TO ACCRUAL
18
2
3
2
1
7
5
1
2
5
1
4
2
2
4
1
3
1
12
3
11
2
1
1
1
1
8
1
3
5
4
2
4
3
2
2
3
13
4
3
2
5
2
3
3
2
1
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL *
1
2
6
2
1
SWOG-S2015 Phase III OPEN TO ACCRUAL
1
7
4
2
2
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
SOTIO-BOXR1030 Phase I/II OPEN TO ACCRUAL *
2
4
1
2
2
3
10
8
1
2
2
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
14
14
2
1
1
1
1
5
4
3
3
1
4
3
1
1
3
3
1
3
3
1
3
3
1
2
2
1
1
9
6
4
1
1
2
1
1
1
2
2
2
2
1
2
1
2
6
12
7
9
8
6
7
13
1
9
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
2
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL
ALLIANCE-A222004-ANOREXIA Phase III OPEN TO ACCRUAL